A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19

Overview

Journal Heart Fail Clin

Specialty Cardiology & Vascular Diseases

Date 2023 Mar 2

PMID 36863811

Authors

Nima Ghasemzadeh

Nathan Kim

Shy Amlani

Mina Madan

Jay S Shavadia

Aun-Yeong Chong

Alireza Bagherli

Akshay Bagai

Jacqueline Saw

Jyotpal Singh

Payam Dehghani

Affiliations

Soon will be listed here.

Abstract

The Coronavirus disease 2019 (COVID-19) pandemic has led to a significant increase in worldwide morbidity and mortality. Patients with COVID-19 are at risk for developing a variety of cardiovascular conditions including acute coronary syndromes, stress-induced cardiomyopathy, and myocarditis. Patients with COVID-19 who develop ST-elevation myocardial infarction (STEMI) are at a higher risk of morbidity and mortality when compared with their age- and sex-matched STEMI patients without COVID-19. We review current knowledge on the pathophysiology of STEMI in patients with COVID-19, clinical presentation, outcomes, and the effect of the COVID-19 pandemic on overall STEMI care.

Citing Articles

Coronary Implications of COVID-19.

Triantafyllis A, Sfantou D, Karapedi E, Peteinaki K, Kotoulas S, Saad R Med Princ Pract. 2024; 34(1):1-12.

PMID: 39307131 PMC: 11805551. DOI: 10.1159/000541553.

COVID-19 Infection and ST-Elevation Myocardial Infarction: Lessons in Disease Management During a Pandemic.

Carmichael A, Hale J, Notta S, Haddadin T, Jbara M Cureus. 2024; 16(6):e62008.

PMID: 38984012 PMC: 11233153. DOI: 10.7759/cureus.62008.

References

Hamadeh A, Aldujeli A, Briedis K, Tecson K, Sanz-Sanchez J, Al Dujeili M . Characteristics and Outcomes in Patients Presenting With COVID-19 and ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020; 131:1-6. PMC: 7333635. DOI: 10.1016/j.amjcard.2020.06.063. View

Stefanini G, Montorfano M, Trabattoni D, Andreini D, Ferrante G, Ancona M . ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation. 2020; 141(25):2113-2116. PMC: 7302062. DOI: 10.1161/CIRCULATIONAHA.120.047525. View

Schiavone M, Gobbi C, Biondi-Zoccai G, DAscenzo F, Palazzuoli A, Gasperetti A . Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med. 2020; 9(6). PMC: 7356537. DOI: 10.3390/jcm9061683. View

Mahmud E, Dauerman H, Welt F, Messenger J, Rao S, Grines C . Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency.... J Am Coll Cardiol. 2020; 76(11):1375-1384. PMC: 7173829. DOI: 10.1016/j.jacc.2020.04.039. View

Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B . ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med. 2020; 382(25):2478-2480. PMC: 7182015. DOI: 10.1056/NEJMc2009020. View

Lauridsen M, Butt J, Ostergaard L, Moller J, Hassager C, Gerds T . Incidence of acute myocardial infarction-related cardiogenic shock during corona virus disease 19 (COVID-19) pandemic. Int J Cardiol Heart Vasc. 2020; 31:100659. PMC: 7553065. DOI: 10.1016/j.ijcha.2020.100659. View

Garcia S, Dehghani P, Grines C, Davidson L, Nayak K, Saw J . Initial Findings From the North American COVID-19 Myocardial Infarction Registry. J Am Coll Cardiol. 2021; 77(16):1994-2003. PMC: 8054772. DOI: 10.1016/j.jacc.2021.02.055. View

Pellegrini D, Kawakami R, Guagliumi G, Sakamoto A, Kawai K, Gianatti A . Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study. Circulation. 2021; 143(10):1031-1042. DOI: 10.1161/CIRCULATIONAHA.120.051828. View

Tam C, Cheung K, Lam S, Wong A, Yung A, Sze M . Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China. Catheter Cardiovasc Interv. 2020; 97(2):E194-E197. PMC: 7267252. DOI: 10.1002/ccd.28943. View

10.

Piccolo R, Bruzzese D, Mauro C, Aloia A, Baldi C, Boccalatte M . Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated With the COVID-19 Outbreak. Circulation. 2020; 141(24):2035-2037. PMC: 7294593. DOI: 10.1161/CIRCULATIONAHA.120.047457. View

11.

Welt F, Shah P, Aronow H, Bortnick A, Henry T, Sherwood M . Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am Coll Cardiol. 2020; 75(18):2372-2375. PMC: 7270593. DOI: 10.1016/j.jacc.2020.03.021. View

12.

Garcia S, Albaghdadi M, Meraj P, Schmidt C, Garberich R, Jaffer F . Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. J Am Coll Cardiol. 2020; 75(22):2871-2872. PMC: 7151384. DOI: 10.1016/j.jacc.2020.04.011. View

13.

Garcia S, Stanberry L, Schmidt C, Sharkey S, Megaly M, Albaghdadi M . Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2020; 98(2):217-222. PMC: 7436427. DOI: 10.1002/ccd.29154. View

14.

Bikdeli B, Madhavan M, Jimenez D, Chuich T, Dreyfus I, Driggin E . COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(23):2950-2973. PMC: 7164881. DOI: 10.1016/j.jacc.2020.04.031. View

15.

Levi M, Thachil J, Iba T, Levy J . Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7(6):e438-e440. PMC: 7213964. DOI: 10.1016/S2352-3026(20)30145-9. View

16.

Popovic B, Varlot J, Metzdorf P, Jeulin H, Goehringer F, Camenzind E . Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID-19 infection. Catheter Cardiovasc Interv. 2020; 97(3):E319-E326. PMC: 7405489. DOI: 10.1002/ccd.29114. View

17.

Rashid M, Timmis A, Kinnaird T, Curzen N, Zaman A, Shoaib A . Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic. Heart. 2021; 107(9):734-740. DOI: 10.1136/heartjnl-2020-318356. View

18.

Roffi M, Guagliumi G, Ibanez B . The Obstacle Course of Reperfusion for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic. Circulation. 2020; 141(24):1951-1953. PMC: 7294591. DOI: 10.1161/CIRCULATIONAHA.120.047523. View

19.

Saad M, Kennedy K, Imran H, Louis D, Shippey E, Poppas A . Association Between COVID-19 Diagnosis and In-Hospital Mortality in Patients Hospitalized With ST-Segment Elevation Myocardial Infarction. JAMA. 2021; 326(19):1940-1952. PMC: 8596198. DOI: 10.1001/jama.2021.18890. View

20.

De Filippo O, DAscenzo F, Angelini F, Bocchino P, Conrotto F, Saglietto A . Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med. 2020; 383(1):88-89. PMC: 7224608. DOI: 10.1056/NEJMc2009166. View